| Name | OptiBiotix Health |
|---|---|
| Epic | OPTI |
| Isin | GB00BP0RTP38 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 13.33p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £13.06 | Debt ratio | n/a |
| Shares in issue | 97.94 | Debt-to-equity ratio | n/a |
| P/E ratio | 4.5 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 25.09 |
| Dividend cover | n/a | EPS growth | -59 |
| Earning per share | 2.93 | 52-week high / low | 10.25p / 33.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | OptiBiotix Health |
|---|---|
| Address | 145-147 St John Street, London, EC1V 4PY |
| Telephone | + 44 (0) 203 178 5618 |
| Website | http://www.optibiotix.com |
| Director | Position |
|---|---|
| Mr Stephen O'Hara | CEO |
| Mr Graham Myers | Finance Director |
| Mr Sean Christie | Non-Executive Director |
| Mr Neil Davidson | Non-Executive Chairman |
| Mr Sofia Kolyda | Research and Development Director |
| Assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Reporting date | 31/12/22 | 31/12/21 | 31/12/20 |
| Intangible asssets and goodwill | 1.54 | 2.64 | 2.74 |
| Investments and other non-current assets | 8.15 | 13.65 | 8.96 |
| Total non-current assets | 9.69 | 16.29 | 11.7 |
| Inventory / work in progress | 0.18 | 0.1 | 0.18 |
| Trade and other receivables | 0.52 | 1.55 | 0.65 |
| Cash and equivalents | 1.05 | 2.01 | 0.87 |
| Other current assets and asset held for resale | 0.11 | 0.19 | 0.31 |
| Total of all assets | 11.55 | 20.14 | 13.7 |
| Liabilities £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Short term liabilities | 0.28 | 0.6 | 0.52 |
| Long term liabilities | 0.37 | 1.37 | 1.33 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.64 | 1.97 | 1.85 |
| Net assets £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Net assets | 10.9 | 18.17 | 12 |
| Equity £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Share capital | 1.82 | 1.76 | 1.76 |
| Minority interests | n/a | 0.04 | 0.04 |
| Retained earnings | 3.68 | 11.32 | 5.06 |
| Share premium account | 2.96 | 2.54 | 2.54 |
| Total equity | 10.9 | 18.17 | 12 |
| Income £ (m) | 2022 | 2021 | 2020 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -2.49 | -1.36 | -1.11 |
| Pre-tax profit | 2.44 | 6.18 | 5.71 |